Literature DB >> 4764348

In vitro studies of lymphocytes from patients with plasma cell myeloma. I. Stimulation by mitogens and cytotoxic activities.

H Mellstedt, G Holm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4764348      PMCID： PMC1553898     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  21 in total

1.  Paraproteins, benign or malignant?

Authors:  J R Hobbs
Journal:  Br Med J       Date:  1967-09-16

Review 2.  Cytotoxic effects of lymphoid cells in vitro.

Authors:  P Perlmann; G Holm
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

3.  The glomerular permeability determined by dextran clearance using Sephadex gel filtration.

Authors:  C E Mogensen
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

4.  Differential effects of human granulocytes and lymphocytes on human fibroblasts in vitro.

Authors:  G Lundgren; C F Zukoski; G Möller
Journal:  Clin Exp Immunol       Date:  1968-10       Impact factor: 4.330

5.  Normal immunoglobulins in multiple myeloma: effect of melphalan chemotherapy.

Authors:  R Alexanian; P J Migliore
Journal:  J Lab Clin Med       Date:  1970-02

6.  Cytotoxicity of lymphocytes and its suppression.

Authors:  G Holm; P Perlmann
Journal:  Antibiot Chemother       Date:  1969

7.  Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens.

Authors:  R Alexanian; A Haut; A U Khan; M Lane; E M McKelvey; P J Migliore; W J Stuckey; H E Wilson
Journal:  JAMA       Date:  1969-06-02       Impact factor: 56.272

8.  Quantitative studies on phytohaemagglutinin-induced cytotoxicity by human lymphocytes against homologous cells in tissue culture.

Authors:  G Holm; P Perlmann
Journal:  Immunology       Date:  1967-05       Impact factor: 7.397

9.  Impaired phytohaemagglutinin-induced cytotoxicity in vitro of lymphocytes from patients with Hodgkin's disease or chronic lymphatic leukaemia.

Authors:  G Holm; P Perlmann; B Johansson
Journal:  Clin Exp Immunol       Date:  1967-05       Impact factor: 4.330

10.  Studies on human peripheral blood lymphocytes in vitro. I. Biological and physicochemical properties of the pokeweed mitogen.

Authors:  J Börjeson; R Reisfeld; L N Chessin; P D Welsh; S D Douglas
Journal:  J Exp Med       Date:  1966-11-01       Impact factor: 14.307
View more
  14 in total

1.  Characterization of mononuclear effector cells in human blood.

Authors:  P Hersey; A Edwards; J Edwards
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

2.  In vitro activation of human T and B lymphocytes by pokeweed mitogen.

Authors:  H Mellstedt
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

3.  Modulating effects of monocytes and autologous serum on natural killer capacity in multiple myeloma patients.

Authors:  M T Ventura; R Crollo; E Lasaracina
Journal:  Blut       Date:  1986-02

4.  In vitro studies of lymphocytes from patients with plasma cell myeloma. II. Characterization by cell surface markers.

Authors:  H Mellstedt; M Jondal; G Holm
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

5.  Activation of peripheral T cells of sarcoidosis patients and healthy controls.

Authors:  E Hedfors
Journal:  Clin Exp Immunol       Date:  1974-11       Impact factor: 4.330

6.  Monoclonal lymphocyte population in human plasma cell myeloma.

Authors:  H Mellstedt; S Hammarström; G Holm
Journal:  Clin Exp Immunol       Date:  1974-07       Impact factor: 4.330

7.  Antibody-dependent cellular cytotoxicity in recurrent aphthous ulceration.

Authors:  J S Greenspan; N Gadol; J A Olson; N Talal
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

8.  Defective generation of alloreactive cytotoxic T lymphocytes (CTL) in human monoclonal gammopathies.

Authors:  M Massaia; U Dianzani; A Bianchi; A Camponi; M Boccadoro; A Pileri
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

9.  Granulocyte-monocyte-colony-stimulating factor augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity.

Authors:  G Masucci; P Wersäll; P Ragnhammar; H Mellstedt
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

10.  In-vitro reactions of lymphocytes in rheumatoid arthritis and other rheumatic diseases.

Authors:  K Froebel; R D Sturrock; P Reynolds; A Grennan; A Roxburgh; R N MacSween
Journal:  Ann Rheum Dis       Date:  1979-12       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.